secwatch.observer — SEC 8-K summary
======================================

Issuer:     BICYCLE THERAPEUTICS PLC (BCYC)
CIK:        0001761612
Form:       8-K
Filed at:   2025-06-17T23:59:59+00:00
Accession:  0001104659-25-060316
Event type: other
Sentiment:  neutral
Materiality: 0.15
Item codes: 5.07
LLM model:  deepseek-v4-flash:cloud@v2

Bicycle Therapeutics AGM results: all proposals pass, equity plan amendment sees 22.4% opposition
--------------------------------------------------------------------------------

- Re-elected director Alessandro Riva: 40.0M for, 9.1M against (18.5% opposed).
- Advisory 'say-on-pay' passed with 47.3M for, 1.7M against.
- Ratified PwC as US auditor: 49.1M for, 41K against.
- Approved amendment to 2020 Equity Incentive Plan: 38.1M for, 11.0M against (22.4% against).
- All ordinary resolutions, including re-appointment of UK auditors and adoption of 2024 accounts, passed.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1761612/000110465925060316/0001104659-25-060316-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1761612/000110465925060316/tm2518232d1_8k.htm
  HTML page:      https://secwatch.observer/filing/0001104659-25-060316

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer